公司資料
ATAI Life Sciences 股價、新聞與催化劑
- 股票代碼:
- ATAI
- 交易所:
- NASDAQ
- 產業:
- Life Science Tools
- 所在地:
- Germany with U
股票表現
7.24 USD (-0.28%)
收盤價
最後更新: 2026年8月17日
1.77B USD
市值
股價為何變動
As of Aug 17, 2026, ATAI closed down 0.28% at $7.24. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
atai Life Sciences is a mental-health company building a portfolio around psychedelic and novel neuropsychiatric therapies. Its story is centered on the possibility of new treatment paradigms for depression and related disorders.
所在地與產業分類
Headquartered in Germany with U.S. market exposure and listed on NASDAQ as an ADR, atai has a global mental-health biotech profile.
商業模式特徵
The company depends on clinical data, regulatory progress, and the commercial viability of novel psychiatric treatments.
生技產業定位
atai is a high-catalyst CNS name with strong sensitivity to clinical and regulatory outcomes.
未來催化劑
- ATAI’s key catalysts are BPL-003 and VLS-01, the psychedelic-therapy assets that define the company’s next chapter. The stock will move if the clinical path keeps looking more practical and less experimental.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。